Leukemia microvesicles affect healthy hematopoietic stem cells

Area of Science:

• Cell Biology
• Hematology
• Oncology

Background:

• Microvesicles mediate intercellular communication by transferring genetic material like mRNAs and microRNAs.
• Acute myeloid leukemia (AML) involves leukemic cells dominating the bone marrow microenvironment.
• Understanding interactions between leukemic and healthy cells is crucial for AML research.

Purpose of the Study:

• To investigate the impact of microvesicles derived from AML patients on healthy hematopoietic stem cells (HSCs).
• To determine if AML microvesicles can transfer genetic information and alter HSC function.
• To assess the potential of AML microvesicles to influence HSC survival, proliferation, and stemness.

Main Methods:

• Isolation of microvesicles from AML patient samples.
• Co-incubation of isolated leukemia microvesicles with healthy umbilical cord blood HSCs.
• Assessment of cell count, HSC-specific CD markers (CD34, CD38, CD90, CD117), colony-forming unit (CFU) assays, and microRNA gene expression after 7 days.

Main Results:

• HSCs treated with leukemia microvesicles showed increased cell counts compared to controls.
• Elevated levels of microRNA-21 and microRNA-29a were observed in HSCs exposed to leukemia microvesicles.
• Colony-forming ability was maintained, and key stemness markers (CD34+, CD34+CD38-, CD90+, CD117+) remained at high levels.

Conclusions:

• Leukemia microvesicles can promote HSC survival and proliferation.
• These microvesicles induce deregulation of specific microRNAs in HSCs.
• Despite functional alterations, the stemness of HSCs appears to be preserved following exposure to leukemia microvesicles.